Sort Results:

List of Partnerships

  • 1
  • .....
  • 5
 

Eisiai Partners with Johns Hopkins Brain Science Institute

 

Eisiai Partners with Johns Hopkins Brain Science Institute ("BSi") an institute which is part of Johns Hopkins University to develop new drugs for neurological diseases. Under this joint collaboration,...

Partner: Eisiai Pharmaceuticals
Academic Institute/Non-Profit: Johns Hopkins Brain Science Institute ("BSi")

GSK and Yale to partner on drug discovery development

 

GlaxoSmithKline (GSK) and Yale University will partner to design a new class of molecules to target disease-causing proteins. This is the latest in a string of deals between Yale’s academic researchers a...

Partner: GSK
Academic Institute/Non-Profit: Yale University

Sanofi to Collaborate with UCSF to Develop New Drugs to Treat Diabetes

 

University of California, San Francisco (UCSF) has entered into a broad collaboration agreement with Sanofi to develop new therapies to treat Diabetes (Type 1 & 2). Scientists with deep biology exp...

Partner: Sanofi
Academic Institute/Non-Profit: University of California, San Francisco (UCSF)

Vanderbilt Enters Into Collaboration With BMS to Develop Drugs to treat Parkinsons Disease

 

Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) and Bristol-Myers Squibb Company have entered into a broad collaboration agreement to co-develop new drugs to treat Parkinsons Disease. Under th...

Partner: Bristol-Myers Squibb
Academic Institute/Non-Profit: Vanderbilt Center for Neuroscience Drug Discovery

Novartis and University of Pennsylvania form Alliance in Oncology Area

 

University of Pennsylvania and Novartis have joined hands together to start a new Center for Advanced Cellular Therapies (CACT). The new center will be based out of University of Pennsylvania campus and wi...

Partner: Novartis
Academic Institute/Non-Profit: University of Pennsylvania

Sanofi and Joslin Diabetes Center to Develop New Drugs for Diabetic Care

 

Joslin Diabetes Center a teaching and research affiliate of Harvard Medical School and Sanofi have entered into a partnership agreement to develop new drugs to treat diabetes. Under this collaboration, ...

Partner: Sanofi
Academic Institute/Non-Profit: Joslin Diabetes Center

Astra Zeneca and Broad Institute to Co-develop Antiviral and Antibacterial Drugs

 

Broad Institute and Astrza Zeneca have entered into a two year collaboration agreement to co-develop antiviral and antibacterial drugs. Screening and target hit to lead chemistry will take place at Broa...

Partner: Astra Zeneca
Academic Institute/Non-Profit: Broad Institute

Brigham & Woman's Hospital and Sanofi to Partner in Type 1 Diabetes Space

 

Sanofi and Brigham & Woman's Hospital an affiliate of Harvard University have entered into a joint collaboration to develop new drugs based on novel immunomodulatory approach to treat Type 1 Diabetes. ...

Partner: Sanofi
Academic Institute/Non-Profit: Brigham & Woman's Hospital

GSK and MD Anderson to co-develop new cancer therapeutics

 

GlaxoSmithkline and MD Anderson Cancer Center entered into a co-development and license agreement to develop antibody based therapeutics to treat cancer. Under this agreement MD Anderson grants exclusiv...

Partner: GlaxoSmithkline
Academic Institute/Non-Profit: Institute for Applied Cancer Science, MD Anderson Cancer Center

Vanderbilt and Astra Zeneca to Develop New Drugs to Treat Psychosis and Other Brain Disorders

 

Under a new research collaboration agreement, Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) and Astra Zeneca will work together to develop compounds that act on M4 muscarinic acetylcholine rece...

Partner: Astra Zeneca
Academic Institute/Non-Profit: Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University

  • 1
  • .....
  • 5